MedTrace Logo

Outcomes of Drug Resistant Epileptic Pediatric Patient by Modified Atkins Diet

NCT07275125 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 40

Last updated 2025-12-10

No results posted yet for this study

Summary

To assess clinical outcomes in drug resistant epileptic pediatric patient by modified atkin diet with focusing on following points:

1. Control of seizures(frequency , duration and numbers of hospital admissions) .
2. Quality of life by pediatric quality of life inventory v4.
3. Cognitive function by stanford binet intelligence scale 5th edition.
4. Growth parameters ( weight, height will be combined to report BMI in kg/m\^2).

Conditions

  • Drug Resistant Epilepsy

Sponsors & Collaborators

  • Sohag University

    lead OTHER

Eligibility

Min Age
1 Year
Max Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-12-30
Primary Completion
2026-05-30
Completion
2026-06-30

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07275125 on ClinicalTrials.gov